Feedback / Questions
fluorocyclopentenylcytosine (RX-3117) - Rexahn
Rexahn: Rodman & Renshaw Global Investment Conference
(Rexahn Pharmaceuticals, Inc)
-
Sep 12, 2015 -
Anticipated initiation of proof-of-concept trial for cancer in 2016
Anticipated new trial
•
Oncology
http://wsw.com/webcast/rrshq25/rnn/index.aspx
Sep 12, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.